| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/19/2000 | EP0752989B1 Thiazolylpyrazolinones and their use for protecting technical materials |
| 07/19/2000 | EP0514452B2 Use of insulin sensitizing agents to treat hypertension |
| 07/19/2000 | EP0482208B1 Pyridazinone derivative |
| 07/19/2000 | CN1260793A 4-haloalkyl-3-heterocyclyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 07/19/2000 | CN1260781A Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagoinist activity |
| 07/18/2000 | US6090941 Pharmaceutically active benzoquinazoline compounds |
| 07/18/2000 | US6090833 Polycyclic dihydrothiazoles, their preparation, and use as pharmaceuticals |
| 07/18/2000 | US6090804 Psychological disorders; schizophrenia therapy |
| 07/18/2000 | US6090753 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 07/13/2000 | WO2000040582A1 Cyclic guanidine derivatives and their use as pesticides |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | WO2000040087A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 07/13/2000 | WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 07/13/2000 | DE19900824A1 Substituierte 2-Imino-thiazoline Substituted 2-imino-thiazolines |
| 07/13/2000 | DE19900544A1 Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia |
| 07/13/2000 | DE19900519A1 Substituierte Guanidin-Derivate Substituted guanidine derivatives |
| 07/13/2000 | DE19845405C2 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
| 07/13/2000 | CA2358576A1 Cyclic guanidine derivatives and their use as pesticides |
| 07/13/2000 | CA2358241A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 07/12/2000 | EP1017693A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them |
| 07/12/2000 | EP1017691A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 07/12/2000 | EP1017682A1 Novel angiogenesis inhibitors |
| 07/12/2000 | EP1017677A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
| 07/12/2000 | EP0628041B1 Heterocyclic compounds and their preparation and use |
| 07/12/2000 | CN1259943A Substituted aryluracils |
| 07/12/2000 | CN1054380C Condensed cyclic compounds and their use |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087385 Flavonoid derivatives |
| 07/11/2000 | US6087384 Treating prophylaxis and treatment of a disease associate with death of cells caused by viral diseases, myelodysplasis, neurodegenerative, ischemic and hepatic diseases with a compound having an insulin sensitivity enhancing activity |
| 07/11/2000 | US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids |
| 07/11/2000 | US6087364 Dopamine D4 receptor antagonists |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/11/2000 | US6086865 O-chloracetylcarbamoylfumagillol and interferon; synergistic angiogenesis inhibitory effect |
| 07/06/2000 | WO2000039124A1 Thrombin inhibitors |
| 07/06/2000 | WO2000039119A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | WO2000039118A1 Aromatic amides |
| 07/06/2000 | WO2000039117A1 HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039108A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | WO2000039106A1 Acrylonitrile compounds |
| 07/06/2000 | WO2000039104A1 Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000039101A1 Pyrimidine compounds |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands |
| 07/06/2000 | WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038688A1 Medicinal compositions for treatment of atrial fibrillation |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2361149A1 Aromatic amides |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358095A1 Heteroroaromatic amides as inhibitor of factor xa |
| 07/06/2000 | CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356141A1 Acrylonitrile compounds |
| 07/06/2000 | CA2355744A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | CA2355281A1 Thrombin inhibitors |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2349557A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2348740A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2320730A1 Thrombin or factor xa inhibitors |
| 07/05/2000 | EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 07/05/2000 | EP1015444A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 07/05/2000 | EP1015429A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 07/05/2000 | EP1014982A1 Troglitazone compounds for treating climacteric |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014973A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/05/2000 | EP1014962A1 Antithrombotic agents |
| 07/05/2000 | EP1014953A2 Formulations for hydrophobic pharmaceutical agents |
| 07/05/2000 | EP0882138B1 Stereoselective preparation of 2-substituted succinic derivatives |
| 07/05/2000 | EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | CN1259122A Method for producing chiral 3,4-dehydroprolines |
| 07/05/2000 | CN1054123C Process for producing carbamic acid derivatives |
| 07/04/2000 | US6084130 For treatment of central nervous system disorders |
| 07/04/2000 | US6084120 β-Alkoxyacrylates against malaria |
| 07/04/2000 | US6084102 Covalently linked oligonucleotide minor grove binder conjugates |
| 07/04/2000 | US6083957 Heterocyclic compounds and their preparation and use |
| 07/04/2000 | US6083955 Having a high affinity for drugs, especially endoserine receptors |